Publications

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.

Cheerie D, Meserve MM, Beijer D, Kaiwar C, Newton L, Taylor Tavares AL, Verran AS, Sherrill E, Leonard S, Sanders SJ, Blake E, Elkhateeb N, Gandhi A, Liang NSY, Morgan JT, Verwillow A, Verheijen J, Giles A, Williams S, Chopra M, Croft L, Dafsari HS, Davidson AE, Friedman J, Gregor A, Haque B, Lechner R, Montgomery KA, Ryten M, Schober E, Siegel G, Sullivan PJ, Whittle EF, Zardetto B, Yu TW, Synofzik M, Aartsma-Rus A, Costain G, Lauffer MC, N=1 Collaborative

2025
Characterizing Rare DNA Copy-Number Variants in Pediatric Obsessive-Compulsive Disorder.

Abdallah SB, Olfson E, Cappi C, Greenspun S, Zai G, Rosário MC, Willsey AJ, Shavitt RG, Miguel EC, Kennedy JL, Richter MA, Fernandez TV

2025
Invasive Brain Mapping Identifies Personalized Therapeutic Neuromodulation Targets for Obsessive-Compulsive Disorder.

Lee AM, Kist A, Alvarez J, Sellers KK, Khambhati AN, Sugrue LP, Reid LB, Kadlec K, Fan JM, Allawala AB, Racine CA, Norbu T, Astudillo D, Tremblay-McGaw AG, Becker N, Alhourani A, Starr PA, Chang EF, Krystal AD

2025
Genetic deletion of G protein-coupled receptor 56 aggravates traumatic brain injury through the microglial CCL3/4/5 upregulation targeted to CCR5.

Sha Z, Dong S, Nie M, Liu T, Wu C, Lv C, Liu M, Jiang W, Yuan J, Qian Y, Piao X, Jiang R, Gao C

2025
NICU Voices: Understanding Parent Perspectives of Research in the Neonatal Intensive Care Unit.

Coloma M, Nguyen B, Bartrug WC, Swander LM, Silva KL, Villegas E, Numis A, McQuillen P, Peyvandi S, Rogers EE, Crouch EE, Paredes M

2025
Structure-guided design of partial agonists at an opioid receptor.

Varga BR, Bernhard SM, El Daibani A, Zaidi SA, Lam JH, Aguilar J, Appourchaux K, Nazarova AL, Kouvelis A, Shinouchi R, Hammond HR, Eans SO, Weinreb V, Margolis EB, Fay JF, Huang XP, Pradhan A, Katritch V, McLaughlin JP, Majumdar S, Che T

2025
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.

Sheth U, Öijerstedt L, Heckman MG, White LJ, Heuer HW, Lario Lago A, Forsberg LK, Faber KM, Foroud TM, Rademakers R, Ramos EM, Appleby BS, Bozoki AC, Darby RR, Dickerson BC, Domoto-Reilly K, Galasko DR, Ghoshal N, Graff-Radford NR, Grant IM, Hales CM, Hsiung GR, Huey ED, Irwin D, Kwan JY, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Pressman PS, Roberson ED, Snyder A, Tartaglia MC, Seeley WW, Dickson DW, Rosen HJ, Boeve BF, Boxer AL, Petrucelli L, Gendron TF

2025
A High-Performance Neuroprosthesis for Speech Decoding and Avatar Control.

Kaylo T. Littlejohn, Sean L. Metzger, Alexander B. Silva, David A. Moses, Margaret P. Seaton, Ran Wang, Maximilian E. Dougherty, Jessie R. Liu, Peter Wu, Michael A. Berger, Inga Zhuravleva, Adelyn Tu-Chan, Karunesh Ganguly, Gopala K. Anumanchipalli, Edward F. Chang

2025

Pages